1. Home
  2. FWRD vs CGEM Comparison

FWRD vs CGEM Comparison

Compare FWRD & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Air Corporation

FWRD

Forward Air Corporation

N/A

Current Price

$25.26

Market Cap

708.1M

ML Signal

N/A

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

N/A

Current Price

$9.57

Market Cap

671.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FWRD
CGEM
Founded
1981
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
708.1M
671.7M
IPO Year
1993
2021

Fundamental Metrics

Financial Performance
Metric
FWRD
CGEM
Price
$25.26
$9.57
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$33.67
$28.00
AVG Volume (30 Days)
548.7K
1.5M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,496,734,000.00
N/A
Revenue This Year
$3.18
N/A
Revenue Next Year
$4.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.54
N/A
52 Week Low
$9.79
$5.68
52 Week High
$35.47
$13.33

Technical Indicators

Market Signals
Indicator
FWRD
CGEM
Relative Strength Index (RSI) 60.76 44.82
Support Level $24.54 $10.01
Resistance Level $26.40 $13.10
Average True Range (ATR) 1.04 1.00
MACD 0.05 -0.27
Stochastic Oscillator 64.91 3.73

Price Performance

Historical Comparison
FWRD
CGEM

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: